Drug: Capex Shampoo
Capex® Shampoo 0.01% is supplied as a shampoo formulation with a 12 mg fluocinolone acetonide capsule which is emptied into the shampoo base by the pharmacist at the time of dispensing. After mixing, Capex® Shampoo contains fluocinolone acetonide (6α, 9-Difluro-11β, 16α, 17,21 -tetrahydroxypregna-1,4-diene-3, 20-dione cyclic 16,17-acetal with acetone), a synthetic fluorinated corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primarily synthetic steroids used topically as an anti-inflammatory and antipruritic agents. Chemically, Capex® Shampoo (fluocinolone acetonide topical shampoo) mixture is C24H30F2O8. It has the following structural formula: Fluocinolone acetonide in Capex® Shampoo (fluocinolone acetonide topical shampoo) has the molecular weight of 452.50. It is a white crystalline powder that is odorless, stable in light and melts at 270°F with decomposition; soluble in alcohol, acetone and methanol; slightly soluble in chloroform; insoluble in water. Each fluocinolone capsule contains 12 mg of fluocinolone acetonide, 548 mg of dibasic calcium phosphate dihydrate USP, and 240 mg of talc USP. The shampoo base contains aluminum acetate basic, benzalkonium chloride solution, boric acid, citric acid anhydrous, cocamido-ether-sulfate complex, cocoamine oxide, lauramide DEA, magnesium aluminum silicate, methylparaben, oat flour, propylene glycol, propylparaben, purified water, and fragrances, with D&C Yellow #10 and FD&C Blue #1 as coloring.
Source: http://www.rxlist.com
The following local adverse reactions have been reported infrequently with topical corticosteroids. They may occur more frequently with the use of occlusive dressings, especially with higher potency corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: dryness, folliculitis, acneiform eruptions, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, miliaria, burning, itching, irritation, and hypopigmentation. Read the Capex Shampoo (fluocinolone acetonide topical shampoo) Side Effects Center for a complete guide to possible side effectsLearn More »
Source: http://www.rxlist.com
The pharmacist must empty the contents of the enclosed capsule into the shampoo base prior to dispensing to the patient. This product should be shaken well prior to use. No more than approximately one (1) ounce of the medicated shampoo should be applied to the scalp area once daily, worked into a lather, and allowed to remain on the scalp for approximately 5 minutes. The hair and scalp should then be rinsed thoroughly with water.
Source: http://www.rxlist.com
No information provided. Last reviewed on RxList: 5/8/2009
This monograph has been modified to include the generic and brand name in many instances.
This monograph has been modified to include the generic and brand name in many instances.
Source: http://www.rxlist.com
Capex® Shampoo (fluocinolone acetonide topical shampoo) is a low- to medium-potency corticosteroid indicated for the treatment of Seborrheic Dermatitis of the scalp. This product has not been proven to be effective in other corticosteroid-responsive dermatoses.
Source: http://www.rxlist.com
Capex® Shampoo (fluocinolone acetonide topical shampoo) is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. Last reviewed on RxList: 5/8/2009
This monograph has been modified to include the generic and brand name in many instances.
This monograph has been modified to include the generic and brand name in many instances.
Source: http://www.rxlist.com
Topically applied Capex® Shampoo (fluocinolone acetonide topical shampoo) can be absorbed in sufficient amounts to produce systemic effects (See PRECAUTIONS).
Source: http://www.rxlist.com
Capex® Shampoo (fluocinolone acetonide topical shampoo) is supplied as a two component package: a capsule which contains the active component fluocinolone acetonide 0.01%, and a separate package of liquid shampoo. The pharmacist must mix the content of the capsule into the base at the time of dispensing. Capex® Shampoo (fluocinolone acetonide topical shampoo) is dispensed to the patient in a 6 ounce bottle. Shake well before using. NDC 0299-5500-04 Store between 15° and 30° C (59° and 86° F) in tightly closed containers. Marketed by: Galderma Laboratories, L.P. Ft. Worth, Texas 76177 USA. Mfd. by: Hill Laboratories, Inc. Sanford, Florida 32773 USA. Revised: July 2000. Last reviewed on RxList: 5/8/2009
This monograph has been modified to include the generic and brand name in many instances.
This monograph has been modified to include the generic and brand name in many instances.
Source: http://www.rxlist.com
General Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticoid insufficiency after withdrawal of treatment. Manifestations of Cushing's syndrome, hyperglycemia, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment. Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression. This may be done by using the ACTH stimulation, A.M. plasma cortisol, and urinary free cortisol tests. Patients receiving superpotent corticosteroids should not be treated for more than 2 weeks at a time and only small areas should be treated at any one time due to the increased risk of HPA suppression. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid. Infrequently, signs and symptoms of glucocorticoid insufficiency may occur requiring supplemental systemic corticosteroids. For information on systemic supplementation, see prescribing information for those products. Pediatric patients may be more susceptible to systemic toxicity from equivalent doses due to their larger skin surface to body mass ratios. (See PRECAUTIONS — Pediatric Use). If irritation develops, Capex® Shampoo (fluocinolone acetonide topical shampoo) should be discontinued and appropriate therapy instituted. Allergic contact dermatitis with corticosteroids is usually diagnosed by a failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing. If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of Capex® Shampoo (fluocinolone acetonide topical shampoo) should be discontinued until the infection has been adequately controlled. Laboratory Tests The following tests may be helpful in evaluating patients for HPA axis suppression.
This monograph has been modified to include the generic and brand name in many instances.
- ACTH stimulation test
- A.M. plasma cortisol test
- Urinary free cortisol test
This monograph has been modified to include the generic and brand name in many instances.
Source: http://www.rxlist.com
Search Symptoms, Conditions,
and Medications
Powered by: WebHealthNetwork
Medications Related to Vaccine
Aggregated Health News & Articles
Join Millions
Sign Up For One Of Our
Newsletters
Drug Database Online
Welcome to Vaccine Health Center an online drug guide and dictionary, here you can get drug information and definitaions for most popular pharmaceutical and medicinal drugs, and specifically Capex Shampoo. Find what medications you are taking today.